WO2008026907A1 - Compositions pharmaceutiques comprenant des bisphosphonates et des vitamines en vue de leur administration hebdomadaire et bimensuelle - Google Patents

Compositions pharmaceutiques comprenant des bisphosphonates et des vitamines en vue de leur administration hebdomadaire et bimensuelle Download PDF

Info

Publication number
WO2008026907A1
WO2008026907A1 PCT/MX2007/000102 MX2007000102W WO2008026907A1 WO 2008026907 A1 WO2008026907 A1 WO 2008026907A1 MX 2007000102 W MX2007000102 W MX 2007000102W WO 2008026907 A1 WO2008026907 A1 WO 2008026907A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
pharmaceutical composition
weight
tablet
lactose
Prior art date
Application number
PCT/MX2007/000102
Other languages
English (en)
Spanish (es)
Inventor
Leopoldo de Jesús ESPINOSA ABDALA
Maria Elena Graciela Armenta
Victor Guillermo ÁLVAREZ OCHOA
Josefina Santos Murillo
Original Assignee
Espinosa Abdala Leopoldo De Je
Maria Elena Graciela Armenta
Alvarez Ochoa Victor Guillermo
Josefina Santos Murillo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from MXPA/A/2006/009804A external-priority patent/MXPA06009804A/xx
Application filed by Espinosa Abdala Leopoldo De Je, Maria Elena Graciela Armenta, Alvarez Ochoa Victor Guillermo, Josefina Santos Murillo filed Critical Espinosa Abdala Leopoldo De Je
Publication of WO2008026907A1 publication Critical patent/WO2008026907A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention se rapporte à la combinaison d'ibandronate monosodique et de vitamine D3 et à son procédé de préparation avec une biodisponibilité améliorée pour le traitement hebdomadaire et bimensuel de malades souffrant d'ostéoporose.
PCT/MX2007/000102 2006-08-29 2007-08-29 Compositions pharmaceutiques comprenant des bisphosphonates et des vitamines en vue de leur administration hebdomadaire et bimensuelle WO2008026907A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MXPA/A/2006/009804A MXPA06009804A (en) 2006-08-29 Pharmaceutical compositions comprising bisphosphonates and vitamins weekly and fortnightly administered
MXPA/A/2006/009804 2006-08-29

Publications (1)

Publication Number Publication Date
WO2008026907A1 true WO2008026907A1 (fr) 2008-03-06

Family

ID=39136139

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MX2007/000102 WO2008026907A1 (fr) 2006-08-29 2007-08-29 Compositions pharmaceutiques comprenant des bisphosphonates et des vitamines en vue de leur administration hebdomadaire et bimensuelle

Country Status (1)

Country Link
WO (1) WO2008026907A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011155728A3 (fr) * 2010-06-10 2012-05-03 주식회사 네비팜 Composition destinée à prévenir ou à traiter l'ostéoporose, et procédé de fabrication de celle-ci
EP2478909A2 (fr) * 2009-09-18 2012-07-25 Hanlim Pharmaceutical Co., Ltd. Compositions pharmaceutiques comprenant des dérivés de bisphosphonate et du cholécalciférol à dose élevée

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030195171A1 (en) * 2002-04-05 2003-10-16 Daifotis Anastasia G. Method for inhibiting bone resorption with an alendronate and vitamin D formulation
JP2004026715A (ja) * 2002-06-25 2004-01-29 Sumitomo Pharmaceut Co Ltd 骨粗鬆症・骨減少症治療剤
WO2004056373A1 (fr) * 2002-12-20 2004-07-08 F. Hoffmann-La Roche Ag Formulation d'ibandronate a forte dose

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030195171A1 (en) * 2002-04-05 2003-10-16 Daifotis Anastasia G. Method for inhibiting bone resorption with an alendronate and vitamin D formulation
JP2004026715A (ja) * 2002-06-25 2004-01-29 Sumitomo Pharmaceut Co Ltd 骨粗鬆症・骨減少症治療剤
WO2004056373A1 (fr) * 2002-12-20 2004-07-08 F. Hoffmann-La Roche Ag Formulation d'ibandronate a forte dose

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
VON TIRPITZ C. ET AL.: "Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate", ALIMENT PHARMACOL. THER., vol. 17, 2003, pages 807 - 816 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2478909A2 (fr) * 2009-09-18 2012-07-25 Hanlim Pharmaceutical Co., Ltd. Compositions pharmaceutiques comprenant des dérivés de bisphosphonate et du cholécalciférol à dose élevée
EP2478909A4 (fr) * 2009-09-18 2014-02-26 Hanlim Pharmaceutical Co Ltd Compositions pharmaceutiques comprenant des dérivés de bisphosphonate et du cholécalciférol à dose élevée
WO2011155728A3 (fr) * 2010-06-10 2012-05-03 주식회사 네비팜 Composition destinée à prévenir ou à traiter l'ostéoporose, et procédé de fabrication de celle-ci
KR101230178B1 (ko) 2010-06-10 2013-02-06 주식회사 네비팜 골다공증 예방 또는 치료용 조성물 및 이의 제조방법
EP2581086A2 (fr) * 2010-06-10 2013-04-17 Navipharm Co, Ltd Composition destinée à prévenir ou à traiter l'ostéoporose, et procédé de fabrication de celle-ci
JP2013528210A (ja) * 2010-06-10 2013-07-08 ナヴィファーム カンパニー リミテッド 骨粗しょう症予防又は治療用組成物及びその製造方法
EP2581086A4 (fr) * 2010-06-10 2014-08-06 Navipharm Co Ltd Composition destinée à prévenir ou à traiter l'ostéoporose, et procédé de fabrication de celle-ci
US9044401B2 (en) 2010-06-10 2015-06-02 Navipharm Co., Ltd. Composition for preventing or treating osteoporosis, and manufacturing method therefor

Similar Documents

Publication Publication Date Title
JP3589977B2 (ja) 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤
JP6173521B2 (ja) ナルブフィンを含有する製剤及びそれらの使用
ES2291749T5 (es) Formulación de altas dosis de ibandronato.
US10420725B2 (en) Solid dosage form of coated bisphosphonate particles
MX2012002786A (es) Composiciones farmaceuticas que comprenden derivados biofosfonato y colecalciferol en alta dosis.
US9044401B2 (en) Composition for preventing or treating osteoporosis, and manufacturing method therefor
WO2008026907A1 (fr) Compositions pharmaceutiques comprenant des bisphosphonates et des vitamines en vue de leur administration hebdomadaire et bimensuelle
CN107106640B (zh) 含有分娩控制物质的口服崩解固体药物剂量单元
JP6374879B2 (ja) 骨粗しょう症治療用の安定な医薬組成物
ES2435966T3 (es) Combinaciones de vildagliptina y glimepirida
CA3154799A1 (fr) Compositions pharmaceutiques solides effervescentes sensiblement exemptes de sodium
RU2590978C1 (ru) Капсулированный препарат для лечения простуды и способ его получения
MXPA06009804A (en) Pharmaceutical compositions comprising bisphosphonates and vitamins weekly and fortnightly administered
KR102136459B1 (ko) 바제독시펜과 비타민 d를 포함하는 복합제제
EP3094334B1 (fr) Composition pharmaceutique renfermant une combinaison d'un bisphosphonate et du cholécalciférol et son procédé de préparation

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07834483

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07834483

Country of ref document: EP

Kind code of ref document: A1